Cyclica Ligand Express

Toronto-based company Cyclica has launched a cloud-based proteome screening platform called Ligand Express. The platform provides users access to the company's AI-assisted, structure-based molecular simulation technology. Users can submit small molecules of interest to rapidly generate unique polypharmacology profiles. These profiles consist of on- and off-target interactions that may be expected, as well as those that are unanticipated, to aid decision making. Off-target interactions can be viewed using the platform's interactive, analytical tools that enable exploration and facilitate deep insights that cannot be gained through traditional target-based approaches.